BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

883 related articles for article (PubMed ID: 29498740)

  • 1. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.
    Freer G; Pistello M
    New Microbiol; 2018 Apr; 41(2):95-105. PubMed ID: 29498740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live attenuated varicella vaccine.
    Arvin AM; Gershon AA
    Annu Rev Microbiol; 1996; 50():59-100. PubMed ID: 8905076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella zoster virus vaccines: potential complications and possible improvements.
    Silver B; Zhu H
    Virol Sin; 2014 Oct; 29(5):265-73. PubMed ID: 25358998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation.
    Bakker KM; Eisenberg MC; Woods RJ; Martinez ME
    BMC Med; 2022 Oct; 20(1):387. PubMed ID: 36209074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging drugs for varicella-zoster virus infections.
    Andrei G; Snoeck R
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the treatment of varicella-zoster virus infections.
    Andrei G; Snoeck R
    Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular studies of the Oka varicella vaccine.
    Quinlivan M; Breuer J; Schmid DS
    Expert Rev Vaccines; 2011 Sep; 10(9):1321-36. PubMed ID: 21919621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?
    Gershon AA
    J Infect; 2017 Jun; 74 Suppl 1(Suppl 1):S27-S33. PubMed ID: 28646959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
    Breuer J; Whitley R
    Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella-zoster virus.
    Arvin AM
    Clin Microbiol Rev; 1996 Jul; 9(3):361-81. PubMed ID: 8809466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella Virus Vaccination in the United States.
    Shaw J; Gershon AA
    Viral Immunol; 2018 Mar; 31(2):96-103. PubMed ID: 29173081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
    Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.
    Amlie-Lefond C; Gilden D
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1561-1569. PubMed ID: 27138380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varicella and herpes zoster vaccine development: lessons learned.
    Warren-Gash C; Forbes H; Breuer J
    Expert Rev Vaccines; 2017 Dec; 16(12):1191-1201. PubMed ID: 29047317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of United Kingdom wild-type strains of varicella-zoster virus: differentiation from the Oka vaccine strain.
    Hawrami K; Breuer J
    J Med Virol; 1997 Sep; 53(1):60-2. PubMed ID: 9298733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs.
    Gabutti G; Franchi M; Maniscalco L; Stefanati A
    Minerva Pediatr; 2016 Jun; 68(3):213-25. PubMed ID: 27125440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella-zoster virus vaccine, successes and difficulties.
    Sarkadi J
    Acta Microbiol Immunol Hung; 2013 Dec; 60(4):379-96. PubMed ID: 24292083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.